ArticleCancer medicine2022

Therapeutic efficacy of proton transport inhibitors alone or in combination with cisplatin in triple negative and hormone sensitive breast cancer models.

Enrica Balza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.